Kane Biotech Inc. (TSXV:KNE)

Kane Biotech Revenue

Kane Biotech had revenue of 8.14K CAD in the quarter ending June 30, 2026, a decrease of -70.91%. In the year 2025, Kane Biotech had annual revenue of 427.87K, down -79.44%. That makes Kane Biotech the 46,875th largest company in the world by revenue and 1,101st in Canada.

• Revenue: 427.87K
• Revenue Growth: -79.44%
• P/S Ratio: 158.88
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 6.15M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Animal Health 410.00K 95.8%
• Human Health 17.87K 4.2%

Fiscal year ended Dec 31, 2025 See the full Kane Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	427.87K	-1.65M	-79.44%
Dec 31, 2024	2.08M	1.93M	1,296.75%
Dec 31, 2023	148.98K	-2.52M	-94.42%
Dec 31, 2022	2.67M	1.06M	65.97%
Dec 31, 2021	1.61M	266.20K	19.84%
Dec 31, 2020	1.34M	-351.95K	-20.78%
Dec 31, 2019	1.69M	1.19M	234.51%
Dec 31, 2018	506.27K	85.80K	20.41%
Dec 31, 2017	420.47K	298.90K	245.87%
Dec 31, 2015	121.57K	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	159.95K	-	-
Dec 31, 2011	-	-	-
Dec 31, 2010	-	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	-	-	-
Dec 31, 2006	-	-	-
Dec 31, 2005	-	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error